Xenon Pharmaceuticals Inc. (XENE)

Xenon Pharmaceuticals Statistics

Total Valuation

XENE has a market cap or net worth of $5.45 billion. The enterprise value is $4.11 billion.

Market Cap	5.45B
Enterprise Value	4.11B

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

XENE has 96.64 million shares outstanding. The number of shares has increased by 4.16% in one year.

Current Share Class	96.64M
Shares Outstanding	96.64M
Shares Change (YoY)	+4.16%
Shares Change (QoQ)	+9.01%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	83.22%
Float	91.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.68
P/TBV Ratio	4.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 27.79

Current Ratio	27.79
Quick Ratio	27.50
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -37.53% and return on invested capital (ROIC) is -25.16%.

Return on Equity (ROE)	-37.53%
Return on Assets (ROA)	-24.22%
Return on Invested Capital (ROIC)	-25.16%
Return on Capital Employed (ROCE)	-30.64%
Weighted Average Cost of Capital (WACC)	7.84%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	370
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.98M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.75% in the last 52 weeks. The beta is 0.65, so XENE's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+59.75%
50-Day Moving Average	55.11
200-Day Moving Average	43.90
Relative Strength Index (RSI)	51.07
Average Volume (20 Days)	919,414

Short Selling Information

The latest short interest is 4.85 million, so 5.02% of the outstanding shares have been sold short.

Short Interest	4.85M
Short Previous Month	4.85M
Short % of Shares Out	5.02%
Short % of Float	5.33%
Short Ratio (days to cover)	4.13

Income Statement

Revenue	n/a
Gross Profit	-300.94M
Operating Income	-412.66M
Pretax Income	-385.15M
Net Income	-383.17M
EBITDA	-410.14M
EBIT	-412.66M
Earnings Per Share (EPS)	-$4.71

Balance Sheet

The company has $1.09 billion in cash and n/a in debt, with a net cash position of $1.34 billion or $13.86 per share.

Cash & Cash Equivalents	1.09B
Total Debt	n/a
Net Cash	1.34B
Net Cash Per Share	$13.86
Equity (Book Value)	1.34B
Book Value Per Share	15.32
Working Capital	1.07B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	2.52M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XENE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.16%
Shareholder Yield	-4.16%
Earnings Yield	-7.02%
FCF Yield	n/a

Analyst Forecast

The average price target for XENE is $70.55, which is 25.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$70.55
Price Target Difference	25.00%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	107.88%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1